- Home
- BWAY vs OPP Comparison
BWAY vs OPP Comparison
Compare BWAY & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- OPP
- Stock Information
- Founded
- BWAY 2003
- OPP 2010
- Country
- BWAY Israel
- OPP United States
- Employees
- BWAY N/A
- OPP N/A
- Industry
- BWAY Medical/Dental Instruments
- OPP Finance/Investors Services
- Sector
- BWAY Health Care
- OPP Finance
- Exchange
- BWAY Nasdaq
- OPP Nasdaq
- Market Cap
- BWAY 216.8M
- OPP 199.8M
- IPO Year
- BWAY 2019
- OPP N/A
- Fundamental
- Price
- BWAY $11.47
- OPP $8.62
- Analyst Decision
- BWAY Strong Buy
- OPP
- Analyst Count
- BWAY 2
- OPP 0
- Target Price
- BWAY $14.25
- OPP N/A
- AVG Volume (30 Days)
- BWAY 47.5K
- OPP 108.0K
- Earning Date
- BWAY 08-13-2025
- OPP 01-01-0001
- Dividend Yield
- BWAY N/A
- OPP 14.41%
- EPS Growth
- BWAY N/A
- OPP N/A
- EPS
- BWAY 0.08
- OPP N/A
- Revenue
- BWAY $43,457,000.00
- OPP N/A
- Revenue This Year
- BWAY $341.83
- OPP N/A
- Revenue Next Year
- BWAY $23.42
- OPP N/A
- P/E Ratio
- BWAY $56.90
- OPP N/A
- Revenue Growth
- BWAY 26.86
- OPP N/A
- 52 Week Low
- BWAY $5.98
- OPP $7.26
- 52 Week High
- BWAY $13.66
- OPP $8.83
- Technical
- Relative Strength Index (RSI)
- BWAY 41.46
- OPP 67.29
- Support Level
- BWAY $11.54
- OPP $8.45
- Resistance Level
- BWAY $12.08
- OPP $8.64
- Average True Range (ATR)
- BWAY 0.50
- OPP 0.06
- MACD
- BWAY -0.12
- OPP 0.01
- Stochastic Oscillator
- BWAY 7.20
- OPP 92.12
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.